JPMorgan Chase & Co. Issues Positive Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

by · The Cerbat Gem

Healthpeak Properties (NYSE:DOC – Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $18.00 to $21.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 2.21% from the stock’s current price.

A number of other research firms have also recently commented on DOC. Wells Fargo & Company upped their price objective on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research report on Monday, June 1st. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Scotiabank increased their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Robert W. Baird raised their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, Raymond James Financial started coverage on Healthpeak Properties in a research report on Wednesday, June 17th. They set a “market perform” rating on the stock. Three equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $19.93.

Read Our Latest Research Report on DOC

Healthpeak Properties Trading Down 0.1%

NYSE DOC traded down $0.01 during trading on Wednesday, reaching $20.55. 1,266,874 shares of the stock traded hands, compared to its average volume of 9,099,423. The firm has a market cap of $14.16 billion, a price-to-earnings ratio of 64.05, a price-to-earnings-growth ratio of 3.11 and a beta of 1.05. The stock’s 50-day moving average price is $18.80 and its 200 day moving average price is $17.58. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $20.82.

Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts predict that Healthpeak Properties will post 1.75 EPS for the current year.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.23% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Healthpeak Properties

Several large investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC raised its position in Healthpeak Properties by 7.3% during the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after acquiring an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Healthpeak Properties by 110.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after acquiring an additional 63,930 shares during the period. Woodline Partners LP grew its position in shares of Healthpeak Properties by 41.3% in the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares during the period. Brown Advisory Inc. increased its stake in shares of Healthpeak Properties by 3.1% during the 2nd quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after purchasing an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new position in shares of Healthpeak Properties during the 2nd quarter worth about $3,117,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

See Also